Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 Amino 4 Methylpyridine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100358871C details a high-purity synthesis route for Nevirapine intermediates, offering cost-effective and scalable manufacturing solutions for global pharmaceutical supply chains.
Novel catalytic amination route for Nevirapine intermediate offers high yield and mild conditions. Reduces manufacturing complexity and ensures supply chain stability for global pharmaceutical partners.
Novel L-alanine catalyzed route improves yield and purity for KRAS G12C inhibitor intermediates, offering cost-effective scale-up solutions.
Patent CN101565399A reveals a streamlined 5-step route improving yield to 27% and purity >99%, offering significant supply chain advantages.
Patent CN113603636A details a cost-effective Nickel-catalyzed route for 2-isopropyl-3-amino-4-methylpyridine, offering significant supply chain advantages.
Patent CN112479993A details a cost-effective iron-catalyzed synthesis for KRAS inhibitor intermediates, offering significant supply chain and purity advantages for API manufacturers.
Discover a scalable, eco-friendly synthesis route for KRAS inhibitor intermediate with 33% yield. Reduce costs and supply chain risks for your API production.